Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 74459.53 308.49 (0.42%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
61	Blue Jet Healthcare Ltd.	Q V PT	9,547 Small Cap	504.40 (0.11%)	40.64	4.27	13.68	9.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Park Medi World Ltd.	Q V PT	9,513 Small Cap	220.25 (-0.47%)	36.86	4.53	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	Procter & Gamble Health Ltd.	Q V PT	9,436 Small Cap	5,684.40 (3.15%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Yatharth Hospital & Trauma Care Services Ltd.	Q V PT	8,942 Small Cap	928.05 (0.62%)	49.36	4.9	39.48	45.83	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	Healthcare Global Enterprises Ltd.	Q V+ PT	8,731 Small Cap	584.80 (-1.09%)	522.51	5.42	17.43	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Jupiter Life Line Hospitals Ltd.	Q V PT	8,402 Small Cap	256.30 (-1.69%)	45.07	5.15	25.27	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Aarti Pharmalabs Ltd.	Q V+ PT	7,922 Small Cap	873.65 (-5.81%)	32.61	3.77	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	7,911 Small Cap	3,435.05 (-0.95%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Sanofi India Ltd.	Q V PT	7,380 Small Cap	3,204.40 (0.46%)	17.86	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	Suven Life Sciences Ltd.	Q V+ PT	7,293 Small Cap	258.10 (-2.53%)	N/A	13.1	-12.01	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Thyrocare Technologies Ltd.	Q V PT	7,274 Small Cap	457 (-11.30%)	50.44	13.14	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Bliss GVS Pharma Ltd.	Q V+ PT	6,898 Small Cap	648.40 (-5.00%)	42.79	5.34	9.94	8.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Supriya Lifescience Ltd.	Q V+ PT	6,810 Small Cap	846.20 (-2.56%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Kovai Medical Center & Hospital Ltd.	Q V PT	6,356 Small Cap	5,808.45 (-1.45%)	24.8	4.58	18.09	25.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Morepen Laboratories Ltd.	Q V+ PT	6,230 Small Cap	113.70 (-4.97%)	33.04	4.51	8.73	-11.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Nephrocare Health Services Ltd.	Q V PT	6,194 Small Cap	615.95 (-2.28%)	80.61	5.46	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	FDC Ltd.	Q V PT	6,132 Small Cap	376.65 (-0.13%)	19.53	2.29	9.91	0.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Innova Captab Ltd.	Q V PT	5,900 Small Cap	1,031.10 (-1.87%)	37.75	5.2	31.75	26.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	5,741 Small Cap	176.90 (-3.47%)	3.62	4.36	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Senores Pharmaceuticals Ltd.	Q V PT	5,221 Small Cap	1,133.60 (-6.97%)	39.11	5.21	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	5,217 Small Cap	177.75 (-3.84%)	25.68	2.71	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Orchid Pharma Ltd.	Q V PT	4,989 Small Cap	833.05 (-6.60%)	575.67	3.18	22.33	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	SMS Pharmaceuticals Ltd.	Q V+ PT	4,793 Small Cap	511.75 (5.33%)	46.8	5.95	9.51	7.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	Gujarat Themis Biosyn Ltd.	Q V PT	4,718 Small Cap	362.50 (-3.29%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Artemis Medicare Services Ltd.	Q V PT	4,626 Small Cap	292.20 (-2.01%)	40.32	5.02	21.50	83.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	RPG Life Sciences Ltd.	Q V+ PT	4,255 Small Cap	2,572.40 (-14.13%)	38.89	6.19	42.67	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Evonile Pharma Ltd.	Q V+ PT	4,182 Small Cap	1,693.85 (-6.59%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Gufic Biosciences Ltd.	Q V PT	4,134 Small Cap	412.20 (-1.95%)	56.27	6.01	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	Aarti Drugs Ltd.	Q V PT	3,977 Small Cap	435.70 (-2.95%)	20.8	2.49	3.55	-6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Kwality Pharmaceuticals Ltd.	Q V+ PT	3,604 Small Cap	3,473.55 (-5.63%)	44.47	10.11	13.94	34.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anuh Pharma	87.09	8.86%
Laurus Labs	2,392	6.55%
SMS Pharmaceuticals	511.75	5.33%
Wanbury	189.75	5.10%
Zydus Lifesciences	1,244	4.89%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
RPG Life Sciences	2,572.40	-14.13%
Thyrocare Tech.	457	-11.30%
Gennex Laboratories	8.02	-10.49%
Ind-Swift Labs.	367.40	-10.14%
Cohance Lifesciences	444.45	-7.67%

News about Top Pharma Companies in India

Oct, 2026

Artemis Medicare Services informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Artemis Medicare Services has enclosed the copy of un-audited financial results for the quarter and half year ended September 30, 2026, published in the following newspapers on October 31, 2026: The Financial Express (English National Daily Newspaper- all editions); The Jansatta (Hindi National Daily Newspaper- Delhi edition). The aforesaid results are also accessible on the Company’s website at https://www.artemishospitals.com/investors.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Kovai Medical Center & Hospital informs about updates

Kovai Medical Center & Hospital has informed that it enclosed the details of Adjudication order received by the Company from the Joint Commissioner of Customs, Office of the Principal Commissioner of Customs (Air Cargo),Chennai.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Sanofi India - Quaterly Results

The quarter ended September 2026 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 4917.00 millions.The Profit for the quarter ended September 2026 of Rs. 1167.00 millions grew by 53.55% from Rs. 760.00 millions.Operating profit for the quarter ended September 2026 rose to 1667.00 millions as compared to 1391.00 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202512	202412	% Var
Sales	4917.00	4754.00	3.43	14017.00	14176.00	-1.12	18374.00	20132.00	-8.73
Other Income	55.00	49.00	12.24	161.00	169.00	-4.73	197.00	165.00	19.39
PBIDT	1667.00	1391.00	19.84	4354.00	4179.00	4.19	5110.00	5073.00	0.73
Interest	2.00	4.00	-50.00	8.00	11.00	-27.27	17.00	15.00	13.33
PBDT	1665.00	1114.00	49.46	4346.00	3895.00	11.58	4820.00	4681.00	2.97
Depreciation	88.00	91.00	-3.30	267.00	278.00	-3.96	373.00	367.00	1.63
PBT	1577.00	1023.00	54.15	4079.00	3617.00	12.77	4447.00	4314.00	3.08
TAX	410.00	263.00	55.89	1051.00	967.00	8.69	1180.00	1177.00	0.25
Deferred Tax	3.00	-49.00	-106.12	4.00	-52.00	-107.69	-49.00	-81.00	-39.51
PAT	1167.00	760.00	53.55	3028.00	2650.00	14.26	3267.00	3137.00	4.14
Equity	230.00	230.00	0.00	230.00	230.00	0.00	230.00	230.00	0.00
PBIDTM(%)	33.90	29.26	15.87	31.06	29.48	5.37	27.81	25.20	10.37

Oct, 2026

Bliss GVS Pharma - Quaterly Results

The sales surged to Rs. 2611.30 millions, up 37.27% for the September 2026 quarter as against Rs. 1902.25 millions during the corresponding quarter previous year.The Net Profit of the company reported a remarkable increase of 196.74% to Rs. 735.65 millions from Rs. 247.91 millions in previous same quarter.OP of the company witnessed a marginal growth to 678.74 millions from 438.62 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	2611.30	1902.25	37.27	4827.15	3535.89	36.52	7298.08	6672.05	9.38
Other Income	74.36	135.92	-45.29	161.98	241.85	-33.02	437.19	362.16	20.72
PBIDT	678.74	438.62	54.74	1285.03	872.23	47.33	1787.53	1278.02	39.87
Interest	11.20	27.15	-58.75	15.09	78.27	-80.72	121.14	65.84	83.99
PBDT	1078.40	411.47	162.08	1680.80	793.96	111.70	1644.83	1212.18	35.69
Depreciation	94.71	76.92	23.13	185.01	153.77	20.32	310.20	270.47	14.69
PBT	983.69	334.55	194.03	1495.79	640.19	133.65	1334.63	941.71	41.72
TAX	248.04	86.64	186.29	373.95	181.74	105.76	365.90	252.03	45.18
Deferred Tax	113.72	-27.46	-514.13	146.72	-57.85	-353.62	-59.47	-47.89	24.18
PAT	735.65	247.91	196.74	1121.84	458.45	144.70	968.73	689.68	40.46
Equity	106.33	105.65	0.64	106.33	105.65	0.64	105.79	105.37	0.40
PBIDTM(%)	25.99	23.06	12.73	26.62	24.67	7.92	24.49	19.15	27.87

Oct, 2026

Thyrocare Tech. - Quaterly Results

The sales moved up 26.71% to Rs. 2562.50 millions for the September 2026 quarter as compared to Rs. 2022.30 millions during the year-ago period.The Company has registered profit of Rs. 481.30 millions for the quarter ended September 2026, a growth of 11.85% over Rs. 430.30 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 889.80 millions from 711.90 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	2562.50	2022.30	26.71	4819.10	3811.20	26.45	7742.70	6331.00	22.30
Other Income	29.40	22.80	28.95	64.50	62.40	3.37	133.90	133.40	0.37
PBIDT	889.80	711.90	24.99	1681.00	1316.70	27.67	2697.20	2003.60	34.62
Interest	14.80	6.00	146.67	27.40	12.20	124.59	21.80	26.30	-17.11
PBDT	783.30	705.90	10.96	1561.90	1304.50	19.73	2615.70	1977.30	32.29
Depreciation	125.00	97.00	28.87	237.30	186.50	27.24	511.70	465.20	10.00
PBT	658.30	608.90	8.11	1324.60	1118.00	18.48	2104.00	1512.10	39.14
TAX	177.00	178.60	-0.90	341.60	327.20	4.40	615.90	554.30	11.11
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	43.00	76.60	-43.86
PAT	481.30	430.30	11.85	983.00	790.80	24.30	1488.10	957.80	55.37
Equity	1591.70	529.90	200.38	1591.70	529.90	200.38	1591.70	529.90	200.38
PBIDTM(%)	34.72	35.20	-1.36	34.88	34.55	0.97	34.84	31.65	10.07

Oct, 2026

Senores Pharmaceutic - Quaterly Results

The sales surged to Rs. 356.50 millions, up 27.28% for the September 2026 quarter as against Rs. 280.10 millions during the corresponding quarter previous year.The Company has registered profit of Rs. 77.20 millions for the quarter ended September 2026, a growth of 20.06% over Rs. 64.30 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 158.20 millions from 128.90 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	356.50	280.10	27.28	626.40	441.40	41.91	1060.90	385.40	175.27
Other Income	147.60	186.80	-20.99	243.10	307.60	-20.97	663.50	219.90	201.73
PBIDT	158.20	128.90	22.73	230.40	201.20	14.51	476.70	147.10	224.07
Interest	22.20	15.80	40.51	44.40	33.40	32.93	69.80	65.20	7.06
PBDT	136.00	113.10	20.25	186.00	167.80	10.85	406.90	81.90	396.83
Depreciation	39.30	36.50	7.67	75.40	55.30	36.35	132.30	30.80	329.55
PBT	96.70	76.60	26.24	110.60	112.50	-1.69	274.60	51.10	437.38
TAX	19.50	12.30	58.54	23.10	21.20	8.96	72.10	14.20	407.75
Deferred Tax	-0.60	2.10	-128.57	-0.10	7.10	-101.41	-12.40	-0.30	4033.33
PAT	77.20	64.30	20.06	87.50	91.30	-4.16	202.50	36.90	448.78
Equity	460.50	460.50	0.00	460.54	460.54	0.00	460.50	460.50	0.00
PBIDTM(%)	44.38	46.02	-3.57	36.78	45.58	-19.31	44.93	38.17	17.73

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sun Pharmaceutical Industries Ltd.	4,26,662 Crore
2	Divis Laboratories Ltd.	2,57,903 Crore
3	Torrent Pharmaceuticals Ltd.	1,76,306 Crore
4	Laurus Labs Ltd.	1,29,243 Crore
5	Zydus Lifesciences Ltd.	1,24,089 Crore
6	Apollo Hospitals Enterprise Ltd.	1,20,779 Crore
7	Dr. Reddys Laboratories Ltd.	1,12,699 Crore
8	Cipla Ltd.	1,11,489 Crore
9	Mankind Pharma Ltd.	1,02,797 Crore
10	Aurobindo Pharma Ltd.	96,537 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,635	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,392	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,678	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,928	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,489	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,244	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,350	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Artemis Medicare Services informs about newspaper publication

Kovai Medical Center & Hospital informs about updates

Sanofi India - Quaterly Results

Bliss GVS Pharma - Quaterly Results

Thyrocare Tech. - Quaterly Results

Senores Pharmaceutic - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?